Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Priscila Keiko Matsumoto, Martin"'
Autor:
Edina Poletto, Andrew Oliveira Silva, Ricardo Weinlich, Priscila Keiko Matsumoto Martin, Davi Coe Torres, Roberto Giugliani, Guilherme Baldo
Publikováno v:
Expert Opinion on Biological Therapy. 23:353-364
Autor:
Suely Maymone de Melo, Simone Bittencourt, Enéas Galdini Ferrazoli, Clivandir Severino da Silva, Flavia Franco da Cunha, Flavia Helena da Silva, Roberta Sessa Stilhano, Priscila Martins Andrade Denapoli, Bianca Ferrarini Zanetti, Priscila Keiko Matsumoto Martin, Leonardo Martins Silva, Adara Aurea dos Santos, Leandra Santos Baptista, Beatriz Monteiro Longo, Sang Won Han
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128922 (2015)
Glioblastoma (GBM) is an infiltrative tumor that is difficult to eradicate. Treating GBM with mesenchymal stem cells (MSCs) that have been modified with the HSV-Tk suicide gene has brought significant advances mainly because MSCs are chemoattracted t
Externí odkaz:
https://doaj.org/article/54b309cd0471482b88deb1e3bd04804a
Autor:
Priscila Keiko Matsumoto Martin, Roberta Sessa Stilhano, Vivian Yochiko Samoto, Christina Maeda Takiya, Giovani Bravin Peres, Yara Maria Correa da Silva Michelacci, Flavia Helena da Silva, Vanessa Gonçalves Pereira, Vânia D'Almeida, Fabio Luiz Navarro Marques, Andreia Hanada Otake, Roger Chammas, Sang Won Han
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92420 (2014)
Mucopolysaccharidosis type I (MPSI) is an autosomal recessive disease that leads to systemic lysosomal storage, which is caused by the absence of α-L-iduronidase (IDUA). Enzyme replacement therapy is recognized as the best therapeutic option for MPS
Externí odkaz:
https://doaj.org/article/1a7cce9dd89d4272a2ff63e581f5f0dc
Autor:
Lucas Assis Pereira, Karina Griesi-Oliveira, Karina Tozatto-Maio, Barbara Ferri Moraschi, Andréa L. Sertié, Luiz Vicente Rizzo, Ricardo Weinlich, Davi Coe Coe Torres, Mariana Tereza Lira Benício, Priscila Keiko Matsumoto Martin, Mariana Morato Marques
Publikováno v:
Blood. 138:1857-1857
Background: Although gene editing by CRISPR/Cas9 is a promising curative strategy for inherited and acquired diseases, potential off-targets remain a major concern. Most computational and biochemical methods for off-target search have focused on sing
Autor:
Roberta Sessa Stilhano, Fabio S.M. Yamaguchi, Priscila Keiko Matsumoto Martin, Eduardo A. Silva, Priscilla A. Williams, Sang Won Han, Vivian Yochiko Samoto, Kevin B Wong, Justin L. Madrigal
Publikováno v:
Journal of Controlled Release. 237:42-49
Hydrogels are an especially appealing class of biomaterials for gene delivery vehicles as they can be introduced into the body with minimally invasive procedures and are often applied in tissue engineering and regenerative medicine strategies. In thi
α-l -iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice
Autor:
Yara M. Michelacci, Suely Maymone de Melo, Vivian Yochiko Samoto, Flávia Helena da Silva, Adriana Taveira da Cruz, Vania D'Almeida, Vanessa Gonçalves Pereira, Sang Won Han, Roberta Sessa Stilhano, Miriam Galvonas Jasiulionis, Priscila Keiko Matsumoto Martin, Giovani B. Peres
Publikováno v:
The Journal of Gene Medicine. 17:1-13
Background Mucopolysaccharidose type I (MPSI) is a lysosomal monogenic disease caused by mutations in the gene for α- l-iduronidase (IDUA). MPSI patients need a constant supply of IDUA to alleviate progression of the disease. IDUA gene transfer usin
Autor:
Yukio Nakamura, Priscila Keiko Matsumoto Martin, Dulcineia M. Albuquerque, Ingrid Grazielle Sousa, Carolina Lanaro, Fernando Ferreira Costa, Ryo Kurita
Publikováno v:
Blood. 134:968-968
Sickle cell anemia is a recessive inherited disease caused by a single nucleotide polymorphism in the β-globin gene the resulting substitution of glutamic acid by valine causes red blood cell sickling when deoxygenated. Some hypomethylating agents a
Autor:
Carolina Lanaro, Fernando Ferreira Costa, Ryo Kurita, Priscila Keiko Matsumoto Martin, Yukio Nakamura, Dulcineia M. Albuquerque
Publikováno v:
Blood. 132:3481-3481
Sickle cell disease (SCD) is a serious condition, chronic and undoubtedly represents a public health problem worldwide. SCD is caused by a point mutation in codon 6 of the β globin gene resulting in the production of a structurally abnormal hemoglob
Autor:
Beatriz M. Longo, Clivandir Severino da Silva, Simone Bittencourt, Roberta Sessa Stilhano, Sang Won Han, Priscila Keiko Matsumoto Martin, Bianca Ferrarini Zanetti, Priscila Martins Andrade Denapoli, Flávia Helena da Silva, Adara Aurea dos Santos, Leandra Santos Baptista, Suely Maymone de Melo, Enéas Galdini Ferrazoli, Flavia Franco da Cunha, Leonardo Martins Silva
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128922 (2015)
PLoS ONE
PLoS ONE
Glioblastoma (GBM) is an infiltrative tumor that is difficult to eradicate. Treating GBM with mesenchymal stem cells (MSCs) that have been modified with the HSV-Tk suicide gene has brought significant advances mainly because MSCs are chemoattracted t
Autor:
Priscila Keiko Matsumoto Martin, Marcel da Rocha Chehuen, Tiago Fernandes, Edilamar Menezes de Oliveira, Sang Won Han, Nelson Wolosker, Natan D. Silva, Gloria F. A. Mota, Bruno T. Roseguini, Cláudia Lúcia de Moraes Forjaz
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Increased oxidative stress and inflammation contribute to impaired walking capacity and endothelial dysfunction in patients with intermittent claudication (IC). The goal of the study was to determine the effects of oral treatment with the antioxidant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::432f2082fce5cbc631fbff297bb7c867